Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C15H22N2O |
| Molecular Weight | 246.348 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC1=C(CCN(C)C)C2=C(N1)C=CC(OC)=C2
InChI
InChIKey=ZEYRDXUWJDGTLD-UHFFFAOYSA-N
InChI=1S/C15H22N2O/c1-5-14-12(8-9-17(2)3)13-10-11(18-4)6-7-15(13)16-14/h6-7,10,16H,5,8-9H2,1-4H3
| Molecular Formula | C15H22N2O |
| Molecular Weight | 246.348 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL3371 Sources: https://www.ncbi.nlm.nih.gov/pubmed/10715164 |
16.0 nM [Ki] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Binding of serotonin and N1-benzenesulfonyltryptamine-related analogs at human 5-HT6 serotonin receptors: receptor modeling studies. | 2008-02-14 |
|
| Biochemical and behavioral evidence for antidepressant-like effects of 5-HT6 receptor stimulation. | 2007-04-11 |
|
| 2-Alkyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as novel 5-HT6 receptor agonists. | 2005-10-01 |
|
| DARPP-32 mediates serotonergic neurotransmission in the forebrain. | 2002-03-05 |
|
| 2-Substituted tryptamines: agents with selectivity for 5-HT(6) serotonin receptors. | 2000-03-09 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/17428998
in mice: the day of the tail suspension test, experimental mice were transferred to the experiment room and allowed to acclimatize for 3–4 h. Mice were injected intraperitoneally with saline, EMDT (1, 2.5, 5, 10, or 15 mg/kg), fluoxetine (20 mg/kg), SB271046 (1, 5, or 10 mg/kg), or SB271046 (1, 5, or 10 mg/kg) combined with fluoxetine (20 mg/kg) 30 min before the tail suspension test trial.
Route of Administration:
Intraperitoneal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/17428998
EMDT increases the phosphorylation state of Thr34-DARPP-32 (Dopamine- and cAMP-regulated phosphoprotein) both in brain slices and in the intact brain. In vitro regulation of Thr34-DARPP-32 and Ser845-GluR1 phosphorylation by EDMTA (100 uM) was investigated in slices of neostriatum from wild-type and D1 knock-out mice.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 06:48:36 GMT 2025
by
admin
on
Wed Apr 02 06:48:36 GMT 2025
|
| Record UNII |
GWM65988LJ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
GWM65988LJ
Created by
admin on Wed Apr 02 06:48:36 GMT 2025 , Edited by admin on Wed Apr 02 06:48:36 GMT 2025
|
PRIMARY | |||
|
EMDT
Created by
admin on Wed Apr 02 06:48:36 GMT 2025 , Edited by admin on Wed Apr 02 06:48:36 GMT 2025
|
PRIMARY | |||
|
DTXSID301336792
Created by
admin on Wed Apr 02 06:48:36 GMT 2025 , Edited by admin on Wed Apr 02 06:48:36 GMT 2025
|
PRIMARY | |||
|
6918513
Created by
admin on Wed Apr 02 06:48:36 GMT 2025 , Edited by admin on Wed Apr 02 06:48:36 GMT 2025
|
PRIMARY | |||
|
263744-72-5
Created by
admin on Wed Apr 02 06:48:36 GMT 2025 , Edited by admin on Wed Apr 02 06:48:36 GMT 2025
|
PRIMARY |